MARKET

CMLTU

CMLTU

CM Life Sciences III Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

10.25
-0.04
-0.39%
Closed 16:00 09/24 EDT
OPEN
10.28
PREV CLOSE
10.29
HIGH
10.35
LOW
10.25
VOLUME
6.01K
TURNOVER
--
52 WEEK HIGH
11.52
52 WEEK LOW
10.00
MARKET CAP
565.80M
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
BRIEF-EQRx Presents Phase 3 Data Of Lung Cancer Treatment At ESMO Congress
reuters.com · 09/17 11:07
EQRx Announces Presentation of Phase 3 Data Demonstrating a Progression-Free Survival Benefit with Sugemalimab Consolidation Therapy in Patients with Stage III NSCLC at ESMO Congress 2021
CAMBRIDGE, Mass., September 17, 2021--EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announced a late-breaking mini oral presentation of data from its p...
Business Wire · 09/17 11:00
EQRx Announces Presentation of Updated Data from Pivotal Phase 3 Study of Anti-PD-L1 Antibody Sugemalimab in Combination with Chemotherapy as a First-Line Treatment for Stage IV NSCLC
CAMBRIDGE, Mass., September 14, 2021--EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announced a late-breaking mini oral presentation of updated data fr...
Business Wire · 09/14 00:40
EQRx to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
CAMBRIDGE, Mass., September 07, 2021--EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announced that Alexis Borisy, executive chairman, Melanie Nallicher...
Business Wire · 09/07 12:00
Bleichroeder LP Buys Pioneer Merger Corp, CM Life Sciences III Inc, Isleworth Healthcare ...
GuruFocus News · 08/18 20:38
BRIEF-Eqrx Appoints Richard Buckley As Chief Corporate Affairs Officer
reuters.com · 08/18 12:47
EQRx Appoints Richard Buckley as Chief Corporate Affairs Officer
CAMBRIDGE, Mass., August 18, 2021--EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announced the appointment of Richard Buckley as chief corporate affair...
Business Wire · 08/18 11:00
Sachem Head Capital Management LP Buys Uber Technologies Inc, LivaNova PLC, Carvana Co, Sells ...
GuruFocus News · 08/17 17:38
More
No Data
Learn about the latest financial forecast of CMLTU. Analyze the recent business situations of CM Life Sciences III Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About CMLTU
CM Life Sciences III Inc is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target. The Company intends to execute business combination in the life sciences sector.

Webull offers kinds of CM Life Sciences III Inc stock information, including NASDAQ:CMLTU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CMLTU stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CMLTU stock methods without spending real money on the virtual paper trading platform.